Champions Oncology, Inc.CSBRNASDAQ
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank86
3Y CAGR+15.9%
5Y CAGR+16.8%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
+15.9%/yr
vs -48.1%/yr prior
5Y CAGR
+16.8%/yr
Consistent
Acceleration
+64.0pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive growthNormalizing
PeriodValueYoY Change
20251.62+141.5%
2024-3.90-310.5%
20231.85+78.2%
20221.04-19.5%
20211.29+73.5%
20200.74+10318.6%
20190.01-100.0%
201814.33+9000.5%
20170.16-54.8%
20160.35-